Impact of Curcumin, Raspberry Extract, and Neem Leaf Extract on Rel Protein-Regulated Cell Death/Radiosensitization in Pancreatic Cancer Cells
- 1 October 2011
- journal article
- research article
- Published by Wolters Kluwer Health in Pancreas
- Vol. 40 (7) , 1107-1119
Abstract
Objectives: Nuclear factor κB (NF-κB) plays an intrinsic role in promoting growth, angiogenesis, and metastasis in pancreatic cancer (PC) and serves as a mechanism underlying therapeutic resistance. Accordingly, we investigated the efficacy of bioactive phytochemicals in inhibiting radiotherapy (RT)-induced NF-κB activity, signaling, and NF-κB-dependent regulation of cell death. Methods: Panc-1, BxPC-3, and MIA PaCa-2 cells exposed to 10 Gy (single high dose [SDR]) or 2 Gy/d for 5 days (fractionated radiation [FIR]) with or without curcumin (CUR), neem leaf extract (NLE), or black raspberry extract (RSE) were analyzed. Results: Radiotherapy profoundly induced NF-κB-DNA-binding activity with relatively robust activation after FIR. Curcumin, NLE, and RSE significantly inhibited both constitutive and RT-induced NF-κB. Furthermore, quantitative polymerase chain reaction profiling of 88 NF-κB pathway molecules demonstrated that CUR, NLE, and RSE comprehensively, yet differentially inhibited FIR/SDR-induced genes. Functionally, CUR, NLE, and RSE markedly conferred RT-inhibited cell viability/survival, robustly activated caspase-3/7 activity, and subsequent cell death. More importantly, NF-κB overexpression and silencing studies demonstrate that these compounds potentiate RT-induced cell death by targeting RT-induced NF-κB. Conclusions: These data strongly imply that CUR, NLE, and RSE may serve as effective "deliverables" to potentiate RT in PC cure and further throw light that these phytochemicals-induced cell killing may involve selective regulation of RT-induced NF-κB.Keywords
This publication has 41 references indexed in Scilit:
- Advanced or Metastatic Pancreatic Cancer: Molecular Targeted TherapiesMount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine, 2010
- The complexity of pancreatic ductal cancers and multidimensional strategies for therapeutic targetingThe Journal of Pathology, 2010
- Update on Pancreatic Cancer TreatmentThe Nurse Practitioner, 2010
- Clinical impact of radiotherapy for locally advanced pancreatic cancerJournal of Gastroenterology, 2009
- Locally Advanced Pancreatic CancerJournal of Clinical Oncology, 2005
- Treatment for Pancreatic Cancer: Current Therapy and Continued ProgressGastroenterology, 2005
- Survivin as a Radioresistance Factor in Pancreatic CancerJapanese Journal of Cancer Research, 2000
- Radiosensitivity of human pancreatic cancer cells in vitro and in vivo, and the effect of a new hypoxic cell sensitizer, doranidazoleRadiotherapy and Oncology, 2000
- Role of Bcl-2 family proteins (Bax, Bcl-2 and Bcl-X) on cellular susceptibility to radiation in pancreatic cancer cellsEuropean Journal of Cancer, 1999
- Apoptosis and mitotic cell death: their relative contributions to normal-tissue and tumour radiation responseInternational Journal of Radiation Biology, 1997